Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
4.79
-0.28 (-5.52%)
At close: Aug 19, 2025, 3:59 PM
4.84
1.04%
After-hours: Aug 19, 2025, 04:10 PM EDT

Bolt Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-63.12M -69.2M -88.1M -98.59M
Depreciation & Amortization
1.78M 1.85M 1.67M 1.19M
Stock-Based Compensation
7.41M 9.22M 9.58M 8.5M
Other Working Capital
-8.44M -6.45M -5.83M 13.83M
Other Non-Cash Items
1.08M -1.54M 3.41M 8.56M
Deferred Income Tax
n/a n/a n/a 2.76M
Change in Working Capital
-8.44M -9.86M -3.06M 20.51M
Operating Cash Flow
-61.29M -69.53M -76.5M -57.07M
Capital Expenditures
-41K -206K -1.95M -2.34M
Cash Acquisitions
n/a n/a -59.81M 229.86M
Purchase of Investments
-88.86M -164.99M -180.7M -313.38M
Sales Maturities Of Investments
146.32M 236.23M 240.52M 83.51M
Other Investing Acitivies
148K n/a 59.81M -229.86M
Investing Cash Flow
57.58M 71.04M 57.86M -232.2M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
108K 253K 503K 311.11M
Net Cash Flow
-3.6M 1.77M -18.14M 21.84M
Free Cash Flow
-61.33M -69.73M -78.46M -59.4M